Personalized nutrition by prediction of glycemic responses D Zeevi, T Korem, N Zmora, D Israeli, D Rothschild, A Weinberger, ... Cell 163 (5), 1079-1094, 2015 | 2479 | 2015 |
Artificial sweeteners induce glucose intolerance by altering the gut microbiota J Suez, T Korem, D Zeevi, G Zilberman-Schapira, CA Thaiss, O Maza, ... Nature 514 (7521), 181-186, 2014 | 2358 | 2014 |
You are what you eat: diet, health and the gut microbiota N Zmora, J Suez, E Elinav Nature reviews Gastroenterology & hepatology 16 (1), 35-56, 2019 | 1286 | 2019 |
Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features N Zmora, G Zilberman-Schapira, J Suez, U Mor, M Dori-Bachash, ... Cell 174 (6), 1388-1405. e21, 2018 | 1269 | 2018 |
Transkingdom control of microbiota diurnal oscillations promotes metabolic homeostasis CA Thaiss, D Zeevi, M Levy, G Zilberman-Schapira, J Suez, AC Tengeler, ... Cell 159 (3), 514-529, 2014 | 1262 | 2014 |
The pros, cons, and many unknowns of probiotics J Suez, N Zmora, E Segal, E Elinav Nature medicine 25 (5), 716-729, 2019 | 966 | 2019 |
Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT J Suez, N Zmora, G Zilberman-Schapira, U Mor, M Dori-Bachash, ... Cell 174 (6), 1406-1423. e16, 2018 | 955 | 2018 |
Growth dynamics of gut microbiota in health and disease inferred from single metagenomic samples T Korem, D Zeevi, J Suez, A Weinberger, T Avnit-Sagi, M Pompan-Lotan, ... Science 349 (6252), 1101-1106, 2015 | 459 | 2015 |
Bread affects clinical parameters and induces gut microbiome-associated personal glycemic responses T Korem, D Zeevi, N Zmora, O Weissbrod, N Bar, M Lotan-Pompan, ... Cell metabolism 25 (6), 1243-1253. e5, 2017 | 287 | 2017 |
Non-caloric artificial sweeteners and the microbiome: findings and challenges J Suez, T Korem, G Zilberman-Schapira, E Segal, E Elinav Gut microbes 6 (2), 149-155, 2015 | 247 | 2015 |
Virulence gene profiling and pathogenicity characterization of non-typhoidal Salmonella accounted for invasive disease in humans J Suez, S Porwollik, A Dagan, A Marzel, YI Schorr, PT Desai, V Agmon, ... PloS one 8 (3), e58449, 2013 | 219 | 2013 |
Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation S Federici, S Kredo-Russo, R Valdés-Mas, D Kviatcovsky, E Weinstock, ... Cell 185 (16), 2879-2898. e24, 2022 | 205 | 2022 |
Personalized microbiome-driven effects of non-nutritive sweeteners on human glucose tolerance J Suez, Y Cohen, R Valdés-Mas, U Mor, M Dori-Bachash, S Federici, ... Cell 185 (18), 3307-3328. e19, 2022 | 168 | 2022 |
The interplay between the innate immune system and the microbiota CA Thaiss, M Levy, J Suez, E Elinav Current opinion in immunology 26, 41-48, 2014 | 158 | 2014 |
Probiotics impact the antibiotic resistance gene reservoir along the human GI tract in a person-specific and antibiotic-dependent manner E Montassier, R Valdés-Mas, E Batard, N Zmora, M Dori-Bachash, J Suez, ... Nature microbiology 6 (8), 1043-1054, 2021 | 143 | 2021 |
Moving from probiotics to precision probiotics P Veiga, J Suez, M Derrien, E Elinav Nature microbiology 5 (7), 878-880, 2020 | 142 | 2020 |
The path towards microbiome-based metabolite treatment J Suez, E Elinav Nature microbiology 2 (6), 1-5, 2017 | 128 | 2017 |
Good microbes, bad genes? The dissemination of antimicrobial resistance in the human microbiome A Crits-Christoph, HA Hallowell, K Koutouvalis, J Suez Gut Microbes 14 (1), 2055944, 2022 | 70 | 2022 |
Sieving through gut models of colonization resistance C Mullineaux-Sanders, J Suez, E Elinav, G Frankel Nature microbiology 3 (2), 132-140, 2018 | 63 | 2018 |
Probiotics in the next-generation sequencing era J Suez, N Zmora, E Elinav Gut microbes 11 (1), 77-93, 2020 | 57 | 2020 |